FasterCures
The Future of US Biomedical Research and Innovation: Recommendations for Action
The Future of US Biomedical Research and Innovation: Recommendations for Action
FasterCures is working to build a system that is effective, efficient, and driven by a clear vision: patient needs above all else. We believe that transformative and life-saving science should be fully realized and deliver better treatments to the people who need them.
Practice Areas
Today's biomedical research system is often siloed, bureaucratic, and too slow to meet the needs of patients across the globe. We accelerate biomedical science and innovation to remove unnecessary barriers so that lifesaving and life-enhancing treatments can reach those who need them as rapidly and as safely as possible.
Accelerating Innovation
Advancing Health Around the World
Engaging Patients in Research and Health
Improving the R&D Environment
FasterCures
Most Recent Content
-
Legislative Discussion Draft of the Next-Generation US Clinical Development to Accelerate Cures
On behalf of the FasterCures team at the Milken Institute, thank you for your leadership on clinical trial modernization and for the opportunity to comment on the discussion draft of the Next-Generation US Clinical Development to Accelerate...Read LetterImage
Esther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Health at the Milken Institute, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. A recognized expert in health policy, biomedical innovation, and clinical research, Krofah has extensive experience shaping health initiatives that unite diverse stakeholders, foster collaboration, and motivate action toward shared goals. -
Access Point: Trends in Clinical Trials Transformation #4
FasterCures’ Access Point: Trends in Clinical Trials Transformation is a quarterly horizon scan examining how emerging trends, organizations, and initiatives are transforming clinical trial access and efficiency.Read Report -
The Future of US Biomedical Research and Innovation: Recommendations for Action
The United States biomedical research and innovation enterprise has long been a source of global leadership, scientific breakthroughs, and lifesaving treatments. Decades of investments in research and development have positioned the US as...Read ReportThe United States biomedical research and innovation enterprise has long been a source of global leadership, scientific breakthroughs, and lifesaving treatments.
-
Cross-Disease Platform Approaches: How Shared Infrastructure and Collaborative Models Can De-Risk Next Gen Science for Patients
As scientific innovation accelerates, patient organizations face a growing challenge: how to invest upstream in ways that meaningfully de-risk and accelerate the therapeutic pipeline.View Webinar -
Request for Information on AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program
Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs. US Food and Drug Administration Silver Spring, MD 20993 Re: Notice of Request for Information; AI-Enabled Optimization of Early-Phase Clinical Trials...Read LetterImage
Esther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Health at the Milken Institute, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. A recognized expert in health policy, biomedical innovation, and clinical research, Krofah has extensive experience shaping health initiatives that unite diverse stakeholders, foster collaboration, and motivate action toward shared goals. -
Cancer 2035: A Roadmap for the Future
In February 2026, leaders from across science, medicine, policy, technology, finance, and philanthropy gathered in Washington, DC, to discuss how the cancer model of research and innovation can evolve for the next eraRead Report -
Meet the LeadersLink 2026-2027 Cohort
The 2026–2027 FasterCures’ LeadersLink program cohort has been carefully selected from a highly competitive pool of candidates. We chose nine exceptional individuals to participate in this year’s program. Through a capstone project...Read Article -
Expanding Access to Clinical Trials: Insights from FasterCures’ ENRICH-CT Coalition
In FasterCures’ extensive work to capture lessons learned from the COVID-19 pandemic, it became clear that the US lacked sufficient infrastructure near communities to run trials efficiently or to engage potential participants in the places...Read ArticleImage
Erin Cieslewski
Senior Associate, FasterCuresErin Cieslewski is a senior associate at FasterCures within the Milken Institute, where she contributes to core programmatic projects with a focus on the clinical trials portfolio. -
Access Point: Trends in Clinical Trials Transformation #3
FasterCures’ Access Point: Trends in Clinical Trials Transformation is a quarterly horizon scan examining how emerging trends, organizations, and initiatives are transforming clinical trial access and efficiency.Read Report
Get the latest from FasterCures
Our Team
Manvit Adusumilli
Ayodola Anise
Sung Hee Choe
Erin Cieslewski
Hadly Clark
Isaiah Dennings
Esther Krofah
Michelle McNabb
Sruthi Meka
Raymond Puerini
Kristin Schneeman
Erika Stratmann
Ainslie Tisdale
Amanda Wagner Gee